GlassScriptPhysician profile
Raymond A Ferrara
NPI 1366582140
$3,021.98
in general payments reported to CMS, 2019-2025
30 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $280 · 2021: $424 · 2022: $493 · 2023: $420 · 2024: $451 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,230.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $894.95 | 2019-2025 | Collagenase Santyl, Stravix, Regranex |
| Treace Medical Concepts, INC. | $292.88 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $292.77 | 2021-2024 | Nuzyra |
| Nevro Corp. | $181.29 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $160.46 | 2019-2023 | Krystexxa |
| Wright Medical Technology, INC. | $151.67 | 2019 | |
| Sandoz INC. | $136.72 | 2019-2020 | |
| Organogenesis INC. | $112.67 | 2021-2024 | Apligraf, Puraply, Cygnus Dual |
| Eclipse Technology Solutions INC. | $110.28 | 2022-2024 | |
| Kci USA, INC. | $86.96 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Zimmer Biomet Holdings, INC. | $76.68 | 2020-2021 | |
| Kerecis Limited | $57.91 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.75 | 2020-2021 | |
| Bioventus LLC | $50.21 | 2019 | |
| Integra Lifesciences Corporation | $37.42 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $35.52 | 2025 | Prospera |
| Ani Pharmaceuticals, INC. | $33.14 | 2025 | Purified Cortrophin Gel |
| Amgen INC. | $30.71 | 2025 | Krystexxa |
| Solventum Corporation | $29.13 | 2024 | Activ.A.C., Prevena, V.A.C.Ulta |
| Alfasigma USA, INC. | $28.06 | 2020-2021 | |
| Pfizer INC. | $22.32 | 2019 | |
| Stryker Corporation | $21.44 | 2019 | |
| Urgo Medical North America, LLC | $20.38 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Depuy Synthes Sales INC. | $19.50 | 2019 | |
| Acera Surgical, INC. | $18.44 | 2022 | |
| Ibsa Pharma INC. | $14.53 | 2021 | |
| Hikma Pharmaceuticals USA | $14.42 | 2019 | |
| Nabriva Therapeutics, Plc | $12.69 | 2021 | |
| Sebela Pharmaceuticals INC. | $12.64 | 2019 | |
| Arthrosurface Incorporated | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Ferrara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.